Alzheimer's and Dementia: Translational Research and Clinical Interventions
ESCI-ISI SCOPUS (2015-2025)
2352-8737
Mỹ
Cơ quản chủ quản: WILEY , John Wiley & Sons Inc.
Lĩnh vực:
Psychiatry and Mental HealthNeurology (clinical)
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Inflammation as a central mechanism in Alzheimer's disease
Tập 4 Số 1 - Trang 575-590 - 2018
AbstractAlzheimer's disease (AD) is a progressive neurodegenerative disorder
that is characterized by cognitive decline and the presence of two core
pathologies, amyloid β plaques and neurofibrillary tangles. Over the last
decade, the presence of a sustained immune response in the brain has emerged as
a third core pathology in AD. The sustained activation of the brain's resident
macrophages (micro...
Alzheimer's disease drug development pipeline: 2018
Tập 4 Số 1 - Trang 195-214 - 2018
AbstractIntroductionTreatments for Alzheimer's disease (AD) are needed due to
the growing number of individuals with preclinical, prodromal, and dementia
forms of AD. Drug development for AD therapies can be examined by inspecting the
drug development pipeline as represented on
clinicaltrials.gov.MethodsClinicaltrials.gov was assessed as of January 30, 2018
to determine AD therapies represented in...
Alzheimer's disease drug development pipeline: 2017
Tập 3 Số 3 - Trang 367-384 - 2017
AbstractIntroductionThere is an urgent need to develop new treatments for
Alzheimer's disease (AD) and to understand the drug development process for new
AD therapies.MethodsWe assessed the agents in the AD pipeline as documented in
clinicaltrials.gov for phase I, phase II, and phase III, accessed
1/5/2017.ResultsThere are 105 agents in the AD treatment development pipeline,
of which 25 agents are...
Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health
Tập 3 Số 3 - Trang 291-300 - 2017
AbstractCognitive decline leading to dementia represents a global health burden.
In the absence of targeted pharmacotherapy, lifestyle approaches remain the best
option for slowing the onset of dementia. However, older adults spend very
little time doing moderate to vigorous exercise and spend a majority of time in
sedentary behavior. Sedentary behavior has been linked to poor glycemic control
and...
Amyloid‐associated increases in longitudinal report of subjective cognitive complaints
Tập 4 - Trang 444-449 - 2018
AbstractIntroductionTo investigate whether baseline subjective cognitive
complaints (SCCs) predict longitudinal decline on neuropsychological testing and
whether SCC increases longitudinally, in the setting of high levels of amyloid
burden.MethodsTwo hundred seventy‐nine clinically normal older participants
(mean age = 73.7 ± 6.1 years) from the Harvard Aging Brain Study, a cohort of
community‐dwe...
Accelerating drug development for Alzheimer's disease through the use of data standards
Tập 3 - Trang 273-283 - 2017
AbstractIntroductionThe exceedingly high rate of failed trials in Alzheimer's
disease (AD) calls for immediate attention to improve efficiencies and learning
from past, ongoing, and future trials. Accurate, highly rigorous standardized
data are at the core of meaningful scientific research. Data standards allow for
proper integration of clinical data sets and represent the essential foundation
for...
UB‐311, một loại vắc xin peptide amyloid β UBITh® mới cho bệnh Alzheimer nhẹ Dịch bởi AI
Tập 3 - Trang 262-272 - 2017
Tóm tắtGiới thiệuVắc xin peptide tổng hợp amyloid β (Aβ) mới (UB‐311) đã được
đánh giá trong một thử nghiệm đầu tiên trên người với bệnh nhân mắc bệnh
Alzheimer nhẹ đến trung bình. Chúng tôi mô tả nghiên cứu chuyển giao bao gồm
thiết kế vắc xin, đặc trưng tiền lâm sàng và thử nghiệm lâm sàng giai đoạn I với
kết quả hỗ trợ đưa UB‐311 tiến vào thử nghiệm giai đoạn II đang diễn ra.Phương
phápUB‐311 đ...
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease
Tập 3 - Trang 166-176 - 2017
AbstractIntroductionDiagnosis of Alzheimer's disease (AD) in vivo, by molecular
imaging of amyloid or tau, is constrained because similar changes can be found
in brains of cognitively normal individuals. Butyrylcholinesterase (BChE), which
becomes associated with these structures in AD, could elevate the accuracy of AD
diagnosis by focusing on BChE pathology in the cerebral cortex, a region of
sca...
Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long‐term, placebo‐controlled study of Alzheimer's disease
Tập 2 - Trang 131-139 - 2016
AbstractIntroductionWe present safety results from a study of Gammagard Liquid
intravenous immunoglobulin (IGIV) in patients with probable Alzheimer's
disease.MethodsThis was a placebo‐controlled double‐blind study. Subjects were
randomized to 400 mg/kg (n = 127), 200 mg/kg (n = 135) IGIV, or to 0.25% human
albumin (n = 121) administered every 2 weeks ± 7 days for
18 months.ResultsElevated risk ra...
Insufficient evidence for vitamin E in Alzheimer's disease
Tập 2 - Trang 199-201 - 2016
AbstractVitamin E has recently been suggested to slow down the progression of
Alzheimer's disease. Current evidence is based on three studies in patients with
Alzheimer's disease and one study in patients with mild cognitive impairment
which all together included only 1756 patients. Importantly, two of these
studies were negative, and the two other studies had severe methodological
weaknesses that...